Next Generation Sequencing Congress
Venue: Hilton Waldorf
|Event Date/Time: Nov 16, 2009||End Date/Time: Nov 17, 2009|
Next-generation sequencing technologies are revolutionizing biology by allowing for genome-wide transcription factor binding-site profiling, transcriptome sequencing, and more recently, whole-genome resequencing. These technologies will provide a genome-wide sequence readout as an endpoint to applications ranging from chromatin immunoprecipitation, mutation mapping and polymorphism discovery to noncoding RNA discovery.
Over the 2 days, the conference provides an overview of the current options of next-generation sequencing platforms, technologies, applications and the newest computational tools for the analysis of next-generation sequencing data.
The event will attract over 120 senior-level decision makers working in bioinformatics & data management, next generation sequencing, discovery, RNA profiling, molecular genomics, and clinical & diagnostics development from the UK, Europe and US. This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.
In keeping with Oxford Globalâ€™s highly successful life sciences series, an expert panel of 25 speakers will present a full conference programme covering the following key topics include:
Day 1 â€“ 16th November
â€¢ Next Generation Sequencing â€“ High Throughput Sequencing Platforms: Implementation and Technology Considerations
Sequencing Applications Considerations
â€¢ Applying Next-Generation Sequencing to Cancer and Medical Genetics and Discovery Research
Day 2 â€“ 17th November
â€¢ Next Generation Sequencing Technologies and Bioinformatic Analysis Tools
â€¢ Data Analysis
â€¢ Data Management and Storage Strategies
Delegates are pre-qualified dependent on budget, responsibility and seniority. Delegates are senior-level decision makers, from major pharmaceutical, biotech companies and research institutions based in Europe and typically include VPs, Directors, Managers and Heads of:
Drug Discovery High throughput Technologies Bioinformatics Data Management
Principal Investigation Molecular Profiling/Diagnostics Clinical Development qPCR
Next Generation Sequencing Gene Expression Biostatistics Genomics